Should we give oligomonocytic chronic myelomonocytic leukemia a higher prominence in the next WHO Classification of Haematolymphoid Tumors?

Leukemia. 2023 Jan;37(1):250-251. doi: 10.1038/s41375-022-01760-5. Epub 2022 Nov 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Leukemia, Myelomonocytic, Chronic* / pathology
  • Mutation
  • Neoplasms*
  • World Health Organization